Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/8133Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2010-04-19T04:47:32Z | - |
| dc.date.available | 2010-04-19T04:47:32Z | - |
| dc.date.issued | 2005-10 | - |
| dc.identifier.issn | 0975-1092 (Online); 0972-592X (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/8133 | - |
| dc.description | 420-422 | en_US |
| dc.description.abstract | Glucagon-like peptide-1 (7-36) amide (GLP-1) is the most potent physiological insulinotropic hormone in humans. It is a potent blood glucose-lowering hormone that stimulates the secretion of insulin from pancreatic beta-cells. Scientists of Japan produced large amounts of a GLP-1 analogue, [Ser8, Gln26, Asp34]-GLP-1, which is resistant to trypsin-digestion, as part of a chimeric rice seed storage protein, a 26kDa globulin, in genetically modified rice seeds. Junction sites between GLP-1 analogue and globulin were replaced by tryptic cleavage sites. The highest level of GLP-1 analogue accumulation was ≈20–50μg per seed. We found that GLP-1 analogue derived from trypsin-digested genetically modified rice seeds stimulated insulin secretion from a mouse pancreatic beta-cell line, MIN6. These findings suggest that the consumption of genetically modified rice seeds containing elevated levels of the GLP-1 analogue may control blood glucose levels in humans. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.source | NPR Vol.4(5) [September-October 2005] | en_US |
| dc.title | Food | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | NPR Vol.4(5) [September-October 2005] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| NPR 4(5) 420-422.pdf | 197.45 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.